CT
GILD icon

Clearstead Trust’s Gilead Sciences GILD Stock Holding History

Clearstead Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.3K Hold
485
– – 0.01% 301
2026
Q1 		$67.6K Sell
485
-130
-21% -$18.2K 0.01% 283
2025
Q4 		$75.5K Sell
615
-102
-14% -$12.4K 0.01% 284
2025
Q3 		$79.6K Sell
717
-96
-12% -$10.9K 0.01% 267
2025
Q2 		$90.1K Buy
813
+437
+116% +$46.5K 0.02% 256
2025
Q1 		$42.1K Buy
376
+279
+288% +$28.8K 0.01% 287
2024
Q4 		$8.96K Hold
97
– – ﹤0.01% 365
2024
Q3 		$8.13K Hold
97
– – ﹤0.01% 357
2024
Q2 		$6.66K Sell
97
-36
-27% -$2.4K ﹤0.01% 376
2024
Q1 		$9.74K Buy
133
+97
+269% +$7.46K ﹤0.01% 352
2023
Q4 		$2.92K Hold
36
– – ﹤0.01% 383
2023
Q3 		$2.7K Hold
36
– – ﹤0.01% 406
2023
Q2 		$2.77K Hold
36
– – ﹤0.01% 352
2023
Q1 		$2.99K Hold
36
– – ﹤0.01% 333
2022
Q4 		$3K Hold
36
– – ﹤0.01% 351
2022
Q3 		$2K Buy
+36
New +$2.27K ﹤0.01% 347
2017
Q4 		– Sell
-350
Closed -$28K – 216
2017
Q3 		$28K Hold
350
– – 0.02% 172
2017
Q2 		$25K Buy
+350
New +$23.3K 0.02% 188

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Clearstead Trust's GILD Position: Q2 2026 in Review

Clearstead Trust held its Gilead Sciences (GILD) position steady in Q2 2026 at 485 shares worth $61.3K. The position accounts for 0.01% of the portfolio, ranked #301.

Clearstead Trust first reported a position in GILD in Q2 2017 and has held it in 18 quarters since. The position peaked at $90.1K in Q2 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Clearstead Trust held 485 shares of Gilead Sciences worth $61.3K as of Q2 2026.
  • Clearstead Trust left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.01% of Clearstead Trust's portfolio in Q2 2026, its #301 holding.
  • Clearstead Trust first reported a position in Gilead Sciences in Q2 2017 and has held it in 18 quarters since.
  • Clearstead Trust's Gilead Sciences position peaked at $90.1K in Q2 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Clearstead Trust's 13F filing for Q2 2026, filed 6 Aug 2026.